Made-in-Israel anti-viral nasal spray found effective against COVID
Made-in-Israel anti-viral nasal spray found effective against COVID
Enovid, a spray developed in
Canada by SaNOtize and manufactured in Israel has been found to reduce viral
loads in confirmed COVID-19 cases by 95% in 24 hours and 99% in 72 hours
By JERUSALEM
POST STAFF JULY 11, 2021 18:32
An anti-viral nasal spray
called Enovid that
was developed in Canada and tested in the UK can reduce the viral loads in
confirmed COVID-19 cases by 95% in 24 hours and 99% in 72 hours, a press
release said on Sunday.
The Israeli-manufactured
spray can be used up to five times a day after coming in contact with viruses,
according to the release. It's suitable for children as young as 12 years old,
and the Ministry of Health approved it in January this year. It will go on sale
in the coming week.
"The spray we developed
has been proven not only as a virus blocker that causes Covid-19 but also as a
killer," Dr. Gili Regev, CEO and founder of Snotize (the company that
developed the spray) said.
Since most COVID-19
infections are nasal, SaNOtize believes this is an effective way to reduce the
spread and infection of COVID-19. It has been able to suppress the SARS-CoV-2
virus within two minutes, including the Alpha and Gamma variants, according to
the release. It is currently being tested against the Delta
variant.
The spray employs nitric
oxide as a mechanical and chemical barrier against viral infection in the nose,
which is where respiratory diseases like COVID-19 infiltrate the body.
The spray is also effective
against other respiratory viruses such as those that cause flu.
Comments
Post a Comment